CYTOSORB THERAPEUTIC ECMO Trademark

Trademark Overview


On Thursday, August 8, 2024, a trademark application was filed for CYTOSORB THERAPEUTIC ECMO with the United States Patent and Trademark Office. The USPTO has given the CYTOSORB THERAPEUTIC ECMO trademark a serial number of 98689487. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, February 14, 2025. This trademark is owned by CYTOSORBENTS CORPORATION. The CYTOSORB THERAPEUTIC ECMO trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, absorption devices and polymeric absorption materials for removing material from blood and blood fractions for use during extra corporeal membrane oxygenation
cytosorb therapeutic ecmo

General Information


Serial Number98689487
Word MarkCYTOSORB THERAPEUTIC ECMO
Filing DateThursday, August 8, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateFriday, February 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLE"THERAPEUTIC ECMO"
Goods and ServicesMedical devices, namely, absorption devices and polymeric absorption materials for removing material from blood and blood fractions for use during extra corporeal membrane oxygenation

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCYTOSORBENTS CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events


Event DateEvent Description
Thursday, August 8, 2024NEW APPLICATION ENTERED
Thursday, January 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 14, 2025ASSIGNED TO EXAMINER